If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
217.00    -0.50 (-0.23%)
Bid:
215.00
Ask:
219.00
Spread: 4.00 (1.86%)
Market Cap: £147.96m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Scrip Dividend Reference Price

14 Jun 2024 07:00

RNS Number : 3974S
Helios Underwriting Plc
14 June 2024
 

14 June 2024

Helios Underwriting plc

("Helios" or the "Company")

 

Scrip Dividend Reference Price

Helios, the investment vehicle which builds shareholder value through exposure to Lloyd's, announces that the scrip dividend reference price for the fully paid ordinary shares to be issued to shareholders electing to receive the scrip dividend alternative for the total dividend of 6.0p per share for the year ended 31 December 2023 will be 183.5p per share.

The scrip reference price is calculated as the average of the Company's closing middle market share price for the five consecutive dealing days commencing on the ex-dividend date of 6 June 2024.

The timetable for the proposed scrip dividend, which remains subject to approval at the Company's Annual General Meeting to be held on 28 June 2024, is as follows:

28 June 2024

Final date for receipt of Scrip Dividend Mandate Election forms and CREST Dividend Election Input Messages

12 July 2024

Allotment of New Shares to Certificated and CREST Shareholders and admission for trading

 

For further information, please contact:

 

Helios Underwriting plc

 

Michael Wade - Executive Chairman  Michael.Wade@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)203 965 6441

Deutsche Numis (Nomad and Broker)

 

Giles Rolls / Charles Farquhar

+44 (0)20 7260 1000

 

FTI Consulting

 

Ed Berry / Tom O'Brien

+44 (0)7703 330 199 / +44 (0)7929 021 492

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £507m of capacity for the 2024 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSEAKKDFSELEFA
Date   Source Headline
30th May 20192:14 pmRNSDirector's Disclosure
17th May 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
10th May 20199:30 amRNSTrading Update
29th Mar 20197:00 amRNSQuarterly Syndicate Mid-point Forecasts
29th Jan 20197:00 amRNSDirector Dealing
23rd Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Jan 20192:36 pmRNS2019 Capacity Update
9th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jan 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Dec 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20187:00 amRNSAcquisition of Lloyd's Member 54532L
6th Dec 201812:47 pmRNSCompletion of Acquisition
20th Nov 20187:00 amRNSQuarterly Syndicate Mid-Point Forecasts
15th Nov 20187:00 amRNSAcquisition of Advantage DCP Limited
12th Nov 20187:00 amRNSHelios Capacity Fund
28th Sep 20187:00 amRNSHalf-year Report
26th Sep 20189:06 amRNSAcquisition of Nomina No 505 LLP
3rd Sep 201810:20 amRNSTotal Voting Rights
30th Aug 201811:17 amRNSAcquisition of Fyshe Underwriting LLP
20th Aug 20187:00 amRNSQuarterly Syndicate Mid-Point Forecasts
20th Aug 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Aug 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Aug 20187:00 amRNSProposed acquisition of Fyshe Underwriting LLP
31st Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Jul 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Jun 20182:23 pmRNSResult of AGM
4th Jun 20185:16 pmRNSPosting of circular and notice of AGM
25th May 20187:00 amRNSFinal Results
22nd May 20187:00 amRNSQuarterly Syndicate Mid-Point Forecasts
22nd Mar 20187:00 amRNSQuarterly Syndicate Mid-point Forecasts
15th Jan 20182:25 pmRNSHolding(s) in Company
14th Dec 20173:35 pmRNSDirector/PDMR Shareholding
12th Dec 201712:12 pmRNSReplacement - Holding(s) in Company
12th Dec 20179:30 amRNSHolding(s) in Company
12th Dec 20177:00 amRNSDirector's Dealing
8th Dec 20177:00 amRNSDirector Appointment
1st Dec 20178:52 amRNSDirector's Dealing
29th Nov 20177:00 amRNS2018 Capacity and Trading Statement
21st Nov 20177:00 amRNSQuarterly Syndicate Mid-point Forecasts
21st Nov 20177:00 amRNSAcquisition of Chapman Underwriting Limited
29th Sep 20177:00 amRNSHalf-year Report
26th Sep 20177:00 amRNSAcquisition of Inversanda LLP
16th Aug 20177:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.